Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29

Page 1 <amp-img class='cut-thumb gotoPage' alt='Page 1: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/1.jpg' width="142" height="106" layout="responsive"> Page 2 <amp-img class='cut-thumb gotoPage' alt='Page 2: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/2.jpg' width="142" height="106" layout="responsive"> Page 3 <amp-img class='cut-thumb gotoPage' alt='Page 3: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/3.jpg' width="142" height="106" layout="responsive"> Page 4 <amp-img class='cut-thumb gotoPage' alt='Page 4: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/4.jpg' width="142" height="106" layout="responsive"> Page 5 <amp-img class='cut-thumb gotoPage' alt='Page 5: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/5.jpg' width="142" height="106" layout="responsive"> Page 6 <amp-img class='cut-thumb gotoPage' alt='Page 6: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/6.jpg' width="142" height="106" layout="responsive"> Page 7 <amp-img class='cut-thumb gotoPage' alt='Page 7: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/7.jpg' width="142" height="106" layout="responsive"> Page 8 <amp-img class='cut-thumb gotoPage' alt='Page 8: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/8.jpg' width="142" height="106" layout="responsive"> Page 9 <amp-img class='cut-thumb gotoPage' alt='Page 9: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/9.jpg' width="142" height="106" layout="responsive"> Page 10 <amp-img class='cut-thumb gotoPage' alt='Page 10: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/10.jpg' width="142" height="106" layout="responsive"> Page 11 <amp-img class='cut-thumb gotoPage' alt='Page 11: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/11.jpg' width="142" height="106" layout="responsive"> Page 12 <amp-img class='cut-thumb gotoPage' alt='Page 12: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/12.jpg' width="142" height="106" layout="responsive"> Page 13 <amp-img class='cut-thumb gotoPage' alt='Page 13: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/13.jpg' width="142" height="106" layout="responsive"> Page 14 <amp-img class='cut-thumb gotoPage' alt='Page 14: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/14.jpg' width="142" height="106" layout="responsive"> Page 15 <amp-img class='cut-thumb gotoPage' alt='Page 15: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/15.jpg' width="142" height="106" layout="responsive"> Page 16 <amp-img class='cut-thumb gotoPage' alt='Page 16: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/16.jpg' width="142" height="106" layout="responsive"> Page 17 <amp-img class='cut-thumb gotoPage' alt='Page 17: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/17.jpg' width="142" height="106" layout="responsive"> Page 18 <amp-img class='cut-thumb gotoPage' alt='Page 18: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/18.jpg' width="142" height="106" layout="responsive"> Page 19 <amp-img class='cut-thumb gotoPage' alt='Page 19: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/19.jpg' width="142" height="106" layout="responsive"> Page 20 <amp-img class='cut-thumb gotoPage' alt='Page 20: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/20.jpg' width="142" height="106" layout="responsive"> Page 21 <amp-img class='cut-thumb gotoPage' alt='Page 21: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/21.jpg' width="142" height="106" layout="responsive"> Page 22 <amp-img class='cut-thumb gotoPage' alt='Page 22: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/22.jpg' width="142" height="106" layout="responsive"> Page 23 <amp-img class='cut-thumb gotoPage' alt='Page 23: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/23.jpg' width="142" height="106" layout="responsive"> Page 24 <amp-img class='cut-thumb gotoPage' alt='Page 24: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/24.jpg' width="142" height="106" layout="responsive"> Page 25 <amp-img class='cut-thumb gotoPage' alt='Page 25: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/25.jpg' width="142" height="106" layout="responsive"> Page 26 <amp-img class='cut-thumb gotoPage' alt='Page 26: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/26.jpg' width="142" height="106" layout="responsive"> Page 27 <amp-img class='cut-thumb gotoPage' alt='Page 27: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/27.jpg' width="142" height="106" layout="responsive"> Page 28 <amp-img class='cut-thumb gotoPage' alt='Page 28: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/28.jpg' width="142" height="106" layout="responsive"> Page 29 <amp-img class='cut-thumb gotoPage' alt='Page 29: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/29.jpg' width="142" height="106" layout="responsive"> Page 30 <amp-img class='cut-thumb gotoPage' alt='Page 30: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/30.jpg' width="142" height="106" layout="responsive"> Page 31 <amp-img class='cut-thumb gotoPage' alt='Page 31: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/31.jpg' width="142" height="106" layout="responsive"> Page 32 <amp-img class='cut-thumb gotoPage' alt='Page 32: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/32.jpg' width="142" height="106" layout="responsive"> Page 33 <amp-img class='cut-thumb gotoPage' alt='Page 33: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/33.jpg' width="142" height="106" layout="responsive"> Page 34 <amp-img class='cut-thumb gotoPage' alt='Page 34: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/34.jpg' width="142" height="106" layout="responsive"> Page 35 <amp-img class='cut-thumb gotoPage' alt='Page 35: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/35.jpg' width="142" height="106" layout="responsive"> Page 36 <amp-img class='cut-thumb gotoPage' alt='Page 36: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/36.jpg' width="142" height="106" layout="responsive"> Page 37 <amp-img class='cut-thumb gotoPage' alt='Page 37: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/37.jpg' width="142" height="106" layout="responsive"> Page 38 <amp-img class='cut-thumb gotoPage' alt='Page 38: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/38.jpg' width="142" height="106" layout="responsive"> Page 39 <amp-img class='cut-thumb gotoPage' alt='Page 39: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/39.jpg' width="142" height="106" layout="responsive"> Page 40 <amp-img class='cut-thumb gotoPage' alt='Page 40: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/40.jpg' width="142" height="106" layout="responsive"> Page 41 <amp-img class='cut-thumb gotoPage' alt='Page 41: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/41.jpg' width="142" height="106" layout="responsive"> Page 42 <amp-img class='cut-thumb gotoPage' alt='Page 42: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/42.jpg' width="142" height="106" layout="responsive"> Page 43 <amp-img class='cut-thumb gotoPage' alt='Page 43: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/43.jpg' width="142" height="106" layout="responsive"> Page 44 <amp-img class='cut-thumb gotoPage' alt='Page 44: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/44.jpg' width="142" height="106" layout="responsive"> Page 45 <amp-img class='cut-thumb gotoPage' alt='Page 45: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/45.jpg' width="142" height="106" layout="responsive"> Page 46 <amp-img class='cut-thumb gotoPage' alt='Page 46: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/46.jpg' width="142" height="106" layout="responsive"> Page 47 <amp-img class='cut-thumb gotoPage' alt='Page 47: Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29' src='https://reader030.cupdf.com/reader030/viewer/2022013023/5faec69109b0f2287f10f247/html5/thumbnails/47.jpg' width="142" height="106" layout="responsive">

Scan SPR. SKONSOLIDOWANE ZA 2016 GRUPY - MSRri.masterpharm.pl/userfiles/2016_RS_MPH_Sprawozdanie... · 2017-04-05 · 4.374 6.003 80.810 26 Nota Nota 30 30 Nota 33 Nota 31 Nota 29

Documents

MIT EECS: 6.003 Signal Processing lecture notes (Spring...

6.003 Homework 14 Solutions · 2019. 3. 17. · 6.003....

6.003: Signals and Systems - Massachusetts...

6.003: Signal Processing

6.003 (Fall 2018) November 13, 2018 · 6.003 (Fall 2018)...

6.003 (Fall 2018) November 13, 2018 - Massachusetts...

6.003: Signal Processing Spring 2020 · 1 6.003: Signal...

6.003 Homework #5 Solutions -...

6.003: Signals and Systems - Universitas Brawijaya · 2013....

6.003 Homework 5 Solutions - MIT OpenCourseWare · 6.003...

CASA GENERALIZIA DELL'ORDINE OSPEDALIERO...

6.003: Signals and Systems Lecture 8 October 4,...

6.003 Homework 8 Solutions - MIT OpenCourseWare · 6.003......

6.003 Lecture 14: Fourier Representations

6.003 (Fall 2011) Final Examination December 19,...

6.003 Signal Processing...6.003 Signal Processing Week 6,...